Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela D'Angelo

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Expert Opinion on Pharmacotherapy|November 8, 2013
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuriaRoberto Fogari, Amedeo Mugellini, Annalisa Zoppi, et al.
Cytokine|January 23, 2017
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentationEnzo Emanuele, Emmanouil Peros, Piercarlo Minoretti, et al.
Renal Failure|January 12, 2011
Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binderLorenzo A Calò, Vincenzo Savica, Antonio Piccoli, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 16, 2018
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trialGiuseppe Derosa, Gabriele Catena, Riccardo Raddino, et al.
Frontiers in Medicine|April 9, 2021
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk BiomarkersValeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, et al.
Journal of Nephrology|March 18, 2005
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solutionMarilena Cara, Giovambattista Virga, Stefania Mastrosimone, et al.
International Journal of Molecular Medicine|January 14, 2004
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart diseaseEmmanouil Peros, Diego Geroldi, Angela D'Angelo, et al.
Expert Opinion on Biological Therapy|August 27, 2013
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patientsGiuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, et al.
Metabolism: Clinical and Experimental|May 31, 2014
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Expert Opinion on Pharmacotherapy|November 8, 2013
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuriaRoberto Fogari, Amedeo Mugellini, Annalisa Zoppi, et al.
Cytokine|January 23, 2017
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentationEnzo Emanuele, Emmanouil Peros, Piercarlo Minoretti, et al.
Renal Failure|January 12, 2011
Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binderLorenzo A Calò, Vincenzo Savica, Antonio Piccoli, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 16, 2018
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trialGiuseppe Derosa, Gabriele Catena, Riccardo Raddino, et al.
Frontiers in Medicine|April 9, 2021
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk BiomarkersValeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, et al.
Journal of Nephrology|March 18, 2005
Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solutionMarilena Cara, Giovambattista Virga, Stefania Mastrosimone, et al.
International Journal of Molecular Medicine|January 14, 2004
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart diseaseEmmanouil Peros, Diego Geroldi, Angela D'Angelo, et al.
Expert Opinion on Biological Therapy|August 27, 2013
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patientsGiuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, et al.
Metabolism: Clinical and Experimental|May 31, 2014
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, et al.
Pageof 20